Sonia Elena Popovici: Redefining Hemorrhagic Shock Through Cellular and Molecular Insights
Sonia Elena Popovici, Specialist in Anesthesiology and Critical Care Medicine at Timișoara Municipal Emergency Clinical Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Biomedicines, adding:
”Pleased to share that our narrative review is now published in Biomedicines (MDPI, Q1):
‘Cellular and Molecular Mechanisms of Hemorrhagic Shock: Biological Rationale for Individualized Fluid Resuscitation Strategies and Multimodal Monitoring’
Biomedicines 2026, 14(8), 1678 — open access.
Hemorrhagic shock is still too often managed as a volume problem. In this review we bring the discussion back to what actually happens at the cellular and molecular level — endothelial and glycocalyx injury, the coagulopathy of trauma, the metabolic shift, and the individual genetic variability that shapes how a given patient responds.
From that biology, we argue for a time-based, individualized approach to resuscitation and for multimodal monitoring rather than a one-size-fits-all protocol.
Grateful to work with this team: Dr. medic Petru Bucuras, Dr. Stelian Adrian Ritiu, Prof. Dr. Marius Papurica, Prof. Dr. Dorel Sandesc, Dr. Adelina Baloi, Dr. Daiana Toma, Dr. Norbert Wellmann, Dr. Claudiu Rafael Barsac, and Prof. Dr. Ovidiu Bedreag.”
Title: Cellular and Molecular Mechanisms of Hemorrhagic Shock: Biological Rationale for Individualized Fluid Resuscitation Strategies and Multimodal Monitoring
Authors: Stelian Adrian Ritiu, Sonia Elena Popovici, Marius Papurica, Dorel Sandesc, Adelina Baloi, Daiana Toma, Norbert Wellmann, Petru Bucuras, Claudiu Rafael Barsac, Ovidiu Bedreag
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI